Register / Log In

Dr. Reyna named new LUGPA president


Juan Reyna, MD, is the new president of the Large Urology Group Practice Association (LUGPA).

Dr. Reyna, a urologist practicing in San Antonio, was installed in the position during the recent LUGPA annual membership meeting in Chicago.

“As a founding member of LUGPA, I’ve seen the impressive work that’s been done by the organization and its members,” Dr. Reyna said. “I look forward to building upon LUGPA’s successes as we work to support the growth of our member practices, collaborate with other specialty associations, and enhance patient education.”

Dr. Reyna is the founder of Urology San Antonio, an integrated urology practice with 29 physicians, 200 employees, eight urology clinics, and a cancer treatment facility. He led the practice as CEO for 30 years before stepping down in 2012.

Dr. Reyna and his wife, Joni, are the creators of Los Padres, a San Antonio-based non-profit dedicated to improving men’s health by creating community awareness about prostate cancer, particularly the need for early detection. They were also integral to the success of San Antonio’s inaugural ZERO Prostate Cancer Run in September 2013, raising $103,000 for prostate cancer awareness.

Dr. Reyna attended San Antonio College and the University of Texas Pharmacy School. He completed medical school and urology residency at the University of Texas Health Science Center at San Antonio, and surgical residency at Baylor College of Medicine in Houston. He is currently a clinical assistant professor in the division of urology at the University of Texas Health Science Center.


To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
 

The use of voided midstream urine cultures in diagnosing cystitis has limited value but can be modified to avoid undertreatment and inappropriate treatment, according to a recently published study.

Astellas Pharma US, Inc. and Medivation, Inc. have initiated a phase IV trial to evaluate the benefit of continued treatment with enzalutamide (Xtandi) beyond disease progression in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer.

Data are lacking to recommend for or against the use of vitamins, minerals, and multivitamin supplements for the prevention of cancer and cardiovascular disease, according to a new U.S. Preventive Services Task Force draft recommendation statement.

An investigational minimally invasive device was found safe and effective in limiting rapid pressure changes within the bladder to reduce symptoms of stress urinary incontinence, the authors of a recently published trial reported.